Selective neuronal nitric oxide synthase inhibitors

被引:53
作者
Erdal, EP
Litzinger, EA
Seo, JW
Zhu, YQ
Ji, HT
Silverman, RB [1 ]
机构
[1] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA
[2] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA
[3] Northwestern Univ, Ctr Drug Discovery & Chem Biol, Evanston, IL 60208 USA
关键词
D O I
10.2174/1568026054679317
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This review includes the non-patent literature up to October 2004 that deals with selective neuronal nitric oxide synthase inhibitors (highest potency is for the neuronal isozyme). Some non-selective inhibitors or selective inducible nitric oxide synthase inhibitors are mentioned if they are related to compounds that are discussed; structures of these compounds generally are not given. In vitro inhibition constants are given either as IC50 values or as Ki values. An IC50 value, the inhibitor concentration that produces 50% inhibition in the presence of a constant concentration of substrate, is obtained by extrapolation of several rate data points to 50% inhibition. K-i values are derived from several types of plots that relate the concentration of inhibitor with enzyme velocity in the presence of a variety of substrate concentrations [1]. The K-i value can be estimated from the IC50 value [2]. Although the two inhibition constants are related, they are not the same; generally, the reported Ki values tend to be lower than the IC50 values. If specifics are desired about how the data were collected, then the reader will have to look in the literature cited. No attempt was made to be exhaustive in citing all references related to specific inhibitors; rather, examples of literature references are given for each inhibitor described.
引用
收藏
页码:603 / 624
页数:22
相关论文
共 213 条
[61]  
Gatto E.M., 2000, OXIDAT STRESS DIS, V5, P291
[62]   Active site topologies and cofactor-mediated conformational changes of nitric-oxide synthases [J].
Gerber, NC ;
RodriguezCrespo, I ;
Nishida, CR ;
deMontellano, PRO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) :6285-6290
[63]  
Giacombo C. D., 2003, EXP BIOL MED, V228, P486
[64]   Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors [J].
Gómez-Vidal, JA ;
Martásek, P ;
Roman, LJ ;
Silverman, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) :703-710
[65]   Time-dependence and preliminary SAR studies in inhibition of nitric oxide synthase Isoforms by homologues of thiocitrulline [J].
Goodyer, CLM ;
Chinje, EC ;
Jaffar, M ;
Stratford, IJ ;
Threadgill, MD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (21) :3679-3680
[66]   Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors [J].
Grant, SK ;
Green, BG ;
Stiffey-Wilusz, J ;
Durette, PL ;
Shah, SK ;
Kozarich, JW .
BIOCHEMISTRY, 1998, 37 (12) :4174-4180
[67]   Role of nitric oxide in long-term potentiation of the rat medial vestibular nuclei [J].
Grassi, S ;
Pettorossi, VE .
NEUROSCIENCE, 2000, 101 (01) :157-164
[68]   MACROPHAGE AND ENDOTHELIAL-CELL NITRIC-OXIDE SYNTHESIS - CELL-TYPE SELECTIVE-INHIBITION BY NG-AMINOARGININE, NG-NITROARGININE AND NG-METHYLARGININE [J].
GROSS, SS ;
STUEHR, DJ ;
AISAKA, K ;
JAFFE, EA ;
LEVI, R ;
GRIFFITH, OW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (01) :96-103
[69]   NOS knockouts and neuroprotection [J].
Grünewald, T ;
Beal, MF .
NATURE MEDICINE, 1999, 5 (12) :1354-1355
[70]   Substituted 2-aminopyridines as inhibitors of nitric oxide synthases [J].
Hagmann, WH ;
Caldwell, CG ;
Chen, P ;
Durette, PL ;
Esser, CK ;
Lanza, TJ ;
Kopka, IE ;
Guthikonda, R ;
Shah, SK ;
MacCoss, M ;
Chabin, RM ;
Fletcher, D ;
Grant, SK ;
Green, BG ;
Humes, JL ;
Kelly, TM ;
Luell, S ;
Meurer, R ;
Moore, V ;
Pacholok, SG ;
Pavia, T ;
Williams, HR ;
Wong, KK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (17) :1975-1978